Abstract
The endogenous neuropeptide cholecystokinin, when administered systemically or perispinally, potently antagonizes opiate analgesia produced by foot shock and morphine. Nonopiate foot-shock analgesia is not reduced by this neuropeptide. The spinal cord appears to be a critical site of cholecystokinin action. These experiments suggest a physiological role for cholecystokinin as a specific opiate antagonist in analgesia-mediating systems. A similar mode of action may explain other behavioral effects of cholecystokinin, such as suppression of food intake.
Original language | English (US) |
---|---|
Pages (from-to) | 310-312 |
Number of pages | 3 |
Journal | Science |
Volume | 219 |
Issue number | 4582 |
DOIs | |
State | Published - Jan 1 1983 |